Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.479, 2005-01, pp. : 8-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Imatinib mesylate promising for CML
Inpharma, Vol. 1, Iss. 1303, 2001-01 ,pp. :
Access to resources
Recommend
Imatinib still cost effective for CML
Inpharma, Vol. 1, Iss. 1639, 2008-01 ,pp. :
Surpassing the success of imatinib mesylate in CML
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
Imatinib effective in paediatric CML and ALL
Inpharma, Vol. 1, Iss. 1470, 2005-01 ,pp. :
Imatinib mesylate confers large QOL benefit in CML
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. :